Stay updated on Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.2 is now shown, replacing the previous v3.3.1 revision label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedSite revision updated from v3.2.0 to v3.3.1 with no changes to study content, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe funding/operating-status notice was removed from the page, eliminating information about potential data delays and NIH operations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedThe screenshots show minor UI/layout changes on the study page without changing core study details such as eligibility criteria, endpoints, or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedThe page has been updated to include a notice about government funding impact and an updated version tag from v3.1.0 to v3.2.0.SummaryDifference3%

- Check79 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0, indicating a new release. No other content changes are indicated.SummaryDifference0.1%

Stay in the know with updates to Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page.